Video 01 Oct 2024 VIDEO | Meet The Board | CEO & MD, Paul Anderson The first episode of Orthocell’s ‘Meet the Board’ video series is now live - featuring CEO & MD, Paul Anderson. Orthocell
Video 26 Sep 2024 Launching October 2024 | Meet The Board As part of a special ‘Meet the Board’ video series launching in October 2024, we are pleased to bring you… Orthocell
Video 10 Sep 2024 Ausbiz | Interview with John Van Der Wielen Orthocell Chairman, John Van Der Wielen spoke with ausbiz host Nadine Blayney about the Company’s expansion into Canada with dental… Orthocell
Video 09 Sep 2024 Proactive | Interview with John Van Der Wielen Orthocell Chairman John Van Der Wielen speaks with Proactive’s Tylah Tully about the Company's swift transition from regulatory approval to… Orthocell
Media 06 Sep 2024 The Australian | Orthocell’s collagen-membrane dental-regeneration product Striate+ debuts in Canada Orthocell's entry to to the Canadian market with the first sales of Striate+ has been reported in The Australian in… Orthocell
Company News 06 Sep 2024 First Sales of Striate+™ in New and Significant Market of Canada Orthocell has today announced global distribution partner BioHorizons has recorded a fast transition to first sales of Striate+™ in the… Orthocell
Company News 05 Sep 2024 Petra Capital Research Report | September 2024 Petra Capital has released a research report valuing #Orthocell (ASX:OCC) at A$1.28 per share. The report summarises Orthocell’s revenue growth, and… Orthocell
Company News 29 Jul 2024 Orthocell submits Singapore Regulatory Application for Striate+™ Orthocell has announced its application to market and sell its leading guided bone and tissue repair product Striate+™ in Singapore,… Orthocell
Media 24 Jul 2024 Proactive | Interview with Paul Anderson Orthocell Managing Director Paul Anderson speaks with Jonathan Jackson at Proactive about the Company's seven regulatory applications in progress or… Orthocell
Company News 24 Jul 2024 Orthocell Accelerates Global Market Expansion of Striate+™ and Remplir™ With Seven New Regulatory Applications either in progress or planned Orthocell has announced the accelerated market expansion of Striate+™ and Remplir™, with seven regulatory applications either in progress or planned… Orthocell
